Related Experiment Videos
The Feasibility of Thoracoscopic Resection in Bronchiectasis
Volkan Baysungur1, Talha Dogruyol, Ilhan Ocakcioglu
1*Department of Thoracic Surgery, Sureyyapasa Chest Diseases and Thoracic Surgery Training and Research Hospital †Department of Thoracic Surgery, Marmara University Pendik Training and Research Hospital, Istanbul, Turkey.
Surgical Laparoscopy, Endoscopy & Percutaneous Techniques
|April 18, 2017
Summary
Video-assisted thoracoscopic surgery (VATS) pulmonary resection offers a safe and effective minimally invasive treatment for bronchiectasis, demonstrating low complication rates. This approach provides cosmetic benefits, making it a viable option for patients with benign lung conditions.
Area of Science:
- Thoracic Surgery
- Minimally Invasive Procedures
- Pulmonary Medicine
Background:
- Bronchiectasis presents surgical challenges due to pleural adhesions and complex vasculature.
- Minimally invasive surgery is standard for early lung cancer, but less explored for infectious lung diseases like bronchiectasis.
Purpose of the Study:
- To evaluate the safety and efficacy of video-assisted thoracoscopic surgery (VATS) lobectomy and segmentectomy in treating bronchiectasis.
- To assess the feasibility of VATS for benign lung conditions, offering cosmetic advantages.
Main Methods:
- Retrospective analysis of patients undergoing VATS lobectomy or segmentectomy for bronchiectasis between 2008 and 2015.
- Inclusion criteria: radiologic evidence of localized bronchiectasis with recurrent infections or significant sputum production.
- Data collected included demographics, conversion rates, postoperative outcomes (drainage, chest tube duration, hospital stay), morbidity, and mortality.
Main Results:
- 41 procedures were completed on 40 patients (15 male, 26 female, average age 31.4 years).
- 40 lobectomies and 1 segmentectomy were performed with a 6.8% thoracotomy conversion rate.
- No major complications or mortality; low rates of prolonged air leak (2 patients) and subcutaneous emphysema (2 patients). Average hospital stay was 4.6 days.
Conclusions:
- VATS pulmonary resection is a safe, feasible, and effective surgical treatment for bronchiectasis.
- The procedure is associated with low morbidity and mortality rates.
- VATS offers cosmetic benefits, making it a suitable minimally invasive option for benign lung diseases like bronchiectasis, similar to malignant conditions.